SEC Form 4 · accession 0001185185-17-001619
IGC Pharma, Inc. · IGC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Cherin
Officer — CFO, Treasurer and PAO
Period of report
Jul 25, 2017
Accepted (ET)
Jul 31, 2017 · 9:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326205
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 25, 2017 | D | 13,000 | $0.43 | D | 350,000 | D |
Table II — derivative securities
No Table II lines on this filing.